The DOI matches its Crossref record.
The Clinical Course of Left Ventricular Hypertrophy in Dialysis Patients
Abstract
To determine the clinical and echocardiographic outcome of left ventricular hypertrophy a prospective study was undertaken of 104 nondiabetic dialysis patients without dilated cardiomyopathy, who were followed for 3-5 years. 33% of patients had normal echocardiogram, 41% mild and 27% severe hypertrophy (left ventricular wall thickness greater than or equal to 1.4 cm in diastole). In the first 2 groups 16% progressed to severe hypertrophy, 23% were admitted with congestive heart failure after starting dialysis therapy, and 2-year cumulative survivals were 97 and 85%. In the group with severe hypertrophy 88% already had severe hypertrophy on starting dialysis therapy, it was persistent in 87%, 50% were admitted at least once with congestive heart failure, and the 2-year cumulative survival was 53%. 71% of those who died in the severe group died from cardiac or cerebrovascular causes compared to none of those with normal echocardiogram, which accounted for the significantly worse (p = 0.001) survival. We conclude that severe left ventricular hypertrophy occurs frequently in dialysis patients, is often present at the start of end-stage renal disease therapy, is persistent, may predispose to congestive heart failure, and is associated with a high mortality.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Clinical and echocardiographic disease in patients starting end-stage renal disease therapy
Foley, R. N., Parfrey, P. S., Harnett, J. D., Kent, G. M., Martin, C. J., Murray, D. C., & Barre, P. E. (1995) · Kidney International · doi:10.1038/ki.1995.22 · Cited by 1,299
Self-citationLevin, A., Singer, J., Thompson, C. R., Ross, H., & Lewis, M. (1996) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(96)90357-1 · Cited by 709
Continuous Relation Between Left Ventricular Mass and Cardiovascular Risk in Essential Hypertension
Schillaci, G., Verdecchia, P., Porcellati, C., Cuccurullo, O., Cosco, C., & Perticone, F. (2000) · Hypertension · doi:10.1161/01.hyp.35.2.580 · Cited by 530
London, G. M., Pannier, B., Guerin, A. P., Blacher, J., Marchais, S. J., Darne, B., Metivier, F., Adda, H., & Safar, M. E. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v12122759 · Cited by 468
Left ventricular mass and cardiovascular morbidity in essential hypertension: the MAVI study
Verdecchia, P., Carini, G., Circo, A., Dovellini, E., Giovannini, E., Lombardo, M., Solinas, P., Gorini, M., & Maggioni, A. P. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01663-1 · Cited by 381
Metadata
- Authors
- Parfrey, P. S., Harriett, J. D., Griffiths, S. M., Taylor, R., Harnett, J. D., King, A., & Barre, P. E.
- Venue
- Nephron
- Publisher
- S. Karger AG
- Published
- 1990
- Volume
- 55
- Issue
- 2
- Pages
- 114-120
- ISSN
- 1660-8151 (ISSN-L)
- 2235-3186
- OpenAlex
- W2056814323
- Cited by
- 178
- References
- 0
- FWCI
- 3.12
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Clinical Course of Left Ventricular Hypertrophy in Dialysis Patients. https://app.cochat.ai/papers/10.1159/000185937
- The paper
- Parfrey, P. S., Harriett, J. D., Griffiths, S. M., Taylor, R., Harnett, J. D., King, A., & Barre, P. E. (1990). The Clinical Course of Left Ventricular Hypertrophy in Dialysis Patients. Nephron. https://doi.org/10.1159/000185937
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.